enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. McKinsey to pay $650 million after advising opioid maker on ...

    www.aol.com/mckinsey-pay-650-million-advising...

    McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue Pharma. ... at Le Bourget Airport near Paris, France, June ...

  3. Endo International - Wikipedia

    en.wikipedia.org/wiki/Endo_International

    Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [44]

  4. Mallinckrodt - Wikipedia

    en.wikipedia.org/wiki/Mallinckrodt

    A US Drug Enforcement Administration (DEA) database tracking every opioid pill sold in the United States from 2006 through 2012 was made public in 2019. The database "attributed the vast majority of the 76 billion opioid pills produced and shipped from 2006 through 2012 to three companies", one of which was SpecGx, a subsidiary of Mallinckrodt.

  5. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/consulting-firm-mckinsey-pay-650...

    McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

  6. List of Schedule II controlled substances (U.S.) - Wikipedia

    en.wikipedia.org/wiki/List_of_Schedule_II...

    This is the list of Schedule II controlled substances in the United States as defined by the ... opiate Codeine [2] 9334 opiate Dihydroetorphine [3] 9190 opiate ...

  7. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/news/consulting-firm-mckinsey-pay...

    BOSTON (Reuters) -McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker ...

  8. McKinsey & Company agrees to pay $650M for helping ... - AOL

    www.aol.com/mckinsey-company-agrees-pay-650...

    McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...

  9. Oxymorphone - Wikipedia

    en.wikipedia.org/wiki/Oxymorphone

    Oxymorphone (sold under the brand names Numorphan and Opana among others) is a highly potent opioid analgesic indicated for treatment of severe pain. Pain relief after injection begins after about 5–10 minutes, after oral administration it begins after about 30 minutes, and lasts about 3–4 hours for immediate-release tablets and 12 hours for extended-release tablets. [6]